NPI: 1699101345 · ISHPEMING, MI 49849 · Critical Access Hospital · NPI assigned 09/25/2013
Authorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
| Authorized Official | LAWRENCE, CHARLOTTE (SECRETARY) |
| NPI Enumeration Date | 09/25/2013 |
Other providers sharing the same authorized official: LAWRENCE, CHARLOTTE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 29,094 | $814K |
| 2019 | 27,512 | $788K |
| 2020 | 26,784 | $1.01M |
| 2021 | 39,007 | $1.47M |
| 2022 | 36,435 | $1.28M |
| 2023 | 33,067 | $1.23M |
| 2024 | 24,829 | $1.07M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 11,640 | 7,897 | $1.75M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 13,175 | 9,454 | $1.54M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3,170 | 2,704 | $1.03M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 7,355 | 5,457 | $524K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3,121 | 2,840 | $391K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 6,823 | 2,067 | $279K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3,841 | 3,682 | $227K |
| 71046 | Radiologic examination, chest; 2 views | 3,063 | 2,940 | $152K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 2,661 | 1,574 | $113K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 499 | 484 | $112K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2,377 | 2,112 | $103K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 2,004 | 684 | $92K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1,946 | 1,758 | $87K |
| 86900 | 1,727 | 1,686 | $85K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 549 | 446 | $71K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 3,665 | 3,509 | $71K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 2,908 | 1,002 | $65K |
| 70450 | Computed tomography, head or brain; without contrast material | 595 | 584 | $58K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1,054 | 900 | $56K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 680 | 680 | $41K |
| 84443 | Thyroid stimulating hormone (TSH) | 4,659 | 4,574 | $41K |
| 80061 | Lipid panel | 3,313 | 3,303 | $40K |
| 36415 | Collection of venous blood by venipuncture | 19,628 | 17,361 | $40K |
| 80053 | Comprehensive metabolic panel | 12,591 | 11,569 | $39K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1,803 | 936 | $36K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1,909 | 1,886 | $31K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1,896 | 1,873 | $31K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 15,242 | 13,720 | $29K |
| 87428 | 938 | 928 | $27K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 364 | 360 | $26K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 128 | 125 | $20K |
| 41899 | Unlisted procedure, dentoalveolar structures | 12 | 12 | $19K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 243 | 237 | $19K |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 184 | 179 | $19K |
| 88142 | 1,463 | 1,454 | $19K | |
| 76830 | Ultrasound, transvaginal | 247 | 243 | $18K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 789 | 788 | $18K |
| 73562 | 489 | 464 | $15K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 468 | 454 | $15K |
| 97161 | 212 | 207 | $14K | |
| 76801 | 186 | 169 | $14K | |
| 73630 | 595 | 564 | $14K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 489 | 483 | $14K |
| 87070 | 3,067 | 3,014 | $13K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,497 | 2,482 | $13K |
| 92526 | 291 | 123 | $13K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 152 | 152 | $12K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 939 | 886 | $12K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1,486 | 1,449 | $12K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 159 | 155 | $11K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2,805 | 2,654 | $11K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1,791 | 1,786 | $11K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 503 | 499 | $10K |
| 71045 | Radiologic examination, chest; single view | 162 | 161 | $10K |
| 73030 | 269 | 255 | $8K | |
| 73610 | 282 | 267 | $8K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 446 | 446 | $8K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2,235 | 2,101 | $7K |
| 84439 | 1,402 | 1,366 | $7K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 3,026 | 2,839 | $7K |
| 86803 | 1,338 | 1,334 | $7K | |
| 87077 | 1,712 | 1,634 | $6K | |
| 59025 | Fetal non-stress test | 68 | 38 | $5K |
| 80305 | 2,347 | 2,169 | $5K | |
| 87186 | 1,446 | 1,386 | $5K | |
| 81001 | 7,278 | 6,709 | $5K | |
| 73130 | 209 | 190 | $5K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 170 | 170 | $5K |
| 82728 | 518 | 514 | $4K | |
| 86592 | 1,133 | 1,129 | $3K | |
| 87590 | 235 | 232 | $3K | |
| 93976 | 48 | 48 | $3K | |
| 87490 | 237 | 232 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 719 | 353 | $2K |
| 87340 | 1,041 | 1,037 | $2K | |
| 82947 | 443 | 437 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2,100 | 1,947 | $2K |
| 87802 | 206 | 205 | $2K | |
| 87807 | 346 | 346 | $2K | |
| 83735 | 1,172 | 1,097 | $2K | |
| 85027 | 349 | 346 | $1K | |
| 82607 | 147 | 145 | $1K | |
| 74019 | 41 | 39 | $1K | |
| 86140 | 743 | 722 | $1K | |
| 0012A | 48 | 48 | $1K | |
| 74018 | 46 | 42 | $1K | |
| 86885 | 33 | 33 | $1K | |
| 81513 | 14 | 14 | $1K | |
| 73502 | 44 | 42 | $1K | |
| 73110 | 58 | 55 | $1K | |
| 82570 | 271 | 259 | $902.06 | |
| 85651 | 539 | 525 | $846.76 | |
| 72100 | 32 | 31 | $841.38 | |
| 0011A | 53 | 52 | $813.45 | |
| 83690 | 2,811 | 2,573 | $728.33 | |
| 85610 | 570 | 493 | $549.23 | |
| 82043 | 142 | 141 | $528.50 | |
| 87210 | 146 | 144 | $500.50 | |
| 84702 | 92 | 72 | $487.79 | |
| 82150 | 1,847 | 1,729 | $480.70 | |
| 81025 | 1,705 | 1,653 | $387.73 | |
| 87088 | 162 | 151 | $372.87 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 15 | 15 | $310.80 |
| 87481 | 14 | 14 | $284.90 | |
| 83540 | 70 | 70 | $274.91 | |
| 87400 | 209 | 207 | $273.02 | |
| 82746 | 29 | 29 | $260.40 | |
| 84703 | 445 | 434 | $258.98 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 402 | 398 | $256.76 |
| 84484 | 1,736 | 1,610 | $235.75 | |
| 86850 | 1,590 | 1,560 | $228.16 | |
| 82550 | 701 | 666 | $184.24 | |
| 83655 | 14 | 14 | $134.12 | |
| 85379 | 496 | 479 | $109.73 | |
| 86704 | 13 | 13 | $90.90 | |
| 86308 | 40 | 39 | $87.65 | |
| 86706 | 13 | 13 | $72.90 | |
| 86762 | 197 | 196 | $64.01 | |
| 83550 | 13 | 13 | $58.61 | |
| 87324 | 13 | 13 | $54.00 | |
| 82948 | 334 | 281 | $40.93 | |
| 82962 | 63 | 62 | $36.64 | |
| 83605 | 81 | 73 | $35.32 | |
| 85730 | 153 | 149 | $34.50 | |
| 88300 | 22 | 12 | $23.22 | |
| 87040 | 98 | 84 | $22.15 | |
| 82553 | 443 | 425 | $16.55 | |
| 80179 | 25 | 25 | $14.91 | |
| 83615 | 15 | 15 | $9.96 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1,686 | 1,504 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 707 | 673 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 714 | 648 | $0.00 |
| 86901 | 1,667 | 1,628 | $0.00 | |
| A9270 | Non-covered item or service | 1,004 | 542 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 1,210 | 1,169 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 918 | 864 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 60 | 38 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 930 | 650 | $0.00 |
| 96376 | 177 | 161 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 29 | 26 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 63 | 44 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1,971 | 1,639 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,340 | 1,257 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 1,713 | 1,160 | $0.00 |
| 94664 | 352 | 340 | $0.00 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 31 | 31 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 40 | 38 | $0.00 |